BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 13732989)

  • 1. [Inhibition of histidine-decarboxylase in vivo].
    PARROT JL
    Therapie; 1961; 16():472-84. PubMed ID: 13732989
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vivo inhibition of histidine decarboxylase by various benzyl-1-isoquinoline derivatives].
    PARROT JL; LABORDE C
    J Physiol (Paris); 1959; 51(3):546-7. PubMed ID: 13665644
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibition of histidine-decarboxylase by cortisone and by sodium salicylate].
    PARROT JL; LABORDE C
    J Physiol (Paris); 1961; 53():441-2. PubMed ID: 13732983
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on inhibition of L-DOPA decarboxylase in vitro and in vivo.
    CLARK WG
    Pharmacol Rev; 1959 Jun; 11(2, Part 2):330-49. PubMed ID: 13667413
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibition of DOPA decarboxylase by alpha-methyl-DOPA in vivo].
    REICHEL G; DENGLER H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 234(4):275-81. PubMed ID: 13600395
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vivo anihistidine-decarboxylasic activity of 2-methyl-6,7-methylendioxy-8-methoxy-1-(4', 5', 6',-triothoxy-7-aminophthalidyl)-1,2,3,4 tetrahydroisoquinoline (tritoqualine)].
    Carpi C; Maggi GC
    Boll Soc Ital Biol Sper; 1968 Mar; 44(6):543-6. PubMed ID: 5674876
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic application of an inhibitor of histidine-decarboxylase].
    THIERS H; MOULIN G; ROUHANI A
    Lyon Med; 1963 Mar; 209():689-94. PubMed ID: 13980982
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of histidine decarboxylases.
    ROBINSON B; SHEPHERD DM
    Biochim Biophys Acta; 1961 Oct; 53():431-3. PubMed ID: 14492884
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of the action of a histidine-decarboxylase inhibitor (L 554) on various allergic manifestations].
    CASTELAIN PY
    Mars Med; 1963; 100():121-9. PubMed ID: 14019175
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of DOPA-decarboxylase by isonicotinic acid hydrazide].
    PALM D
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 234(3):206-9. PubMed ID: 13600389
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of glutamic acid decarboxylase in the brain by means of pyrocatechol derivatives].
    HOLTZ P; WESTERMANN E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1957; 231(4):311-32. PubMed ID: 13526802
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of DOPA decarboxylase in vitro and in vivo.
    CLARK WG; POGRUND RS
    Circ Res; 1961 May; 9():721-33. PubMed ID: 13693869
    [No Abstract]   [Full Text] [Related]  

  • 13. [New microorganism containing decarboxylase of l-histidine].
    GLADKOVA VN; MARDASHEV SR; SEMINA LA
    Mikrobiologiia; 1953; 22(2):141-4. PubMed ID: 13119389
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of a decarboxylase inhibitor on the effects of dopa & dops on blood pressure].
    DENGLER H; REICHEL G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1957; 232(1):324-6. PubMed ID: 13526880
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of aspartic omega-decarboxylase by iso-nicotinic hydrazide].
    CATTANEO-LACOMBE J; SENEZ JC
    C R Seances Soc Biol Fil; 1956 Sep; 150(4):748-50. PubMed ID: 13365199
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research on the mode of action of a new series of derivatives which can be used in the treatment of allergy].
    Parrot JL; Laborde C
    J Physiol (Paris); 1955; 47(1):263. PubMed ID: 13243320
    [No Abstract]   [Full Text] [Related]  

  • 17. Convulsant hydrazides. II. Comparison of electrical changes and enzyme inhibition induced by the administration of thiosemicarbazide.
    KILLAM KF
    J Pharmacol Exp Ther; 1957 Feb; 119(2):263-71. PubMed ID: 13417078
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines.
    Kwiek JJ; Haystead TA; Rudolph J
    Biochemistry; 2004 Apr; 43(15):4538-47. PubMed ID: 15078100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antileishmanial 2-substituted quinolines: in vitro behaviour towards biological components.
    Desrivot J; Herrenknecht C; Ponchel G; Garbi N; Prina E; Fournet A; Bories C; Figadère B; Hocquemiller R; Loiseau PM
    Biomed Pharmacother; 2007 Aug; 61(7):441-50. PubMed ID: 17459651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nematocidal and trichomonacidal activities of 2-substituted quinolines.
    Martínez-Grueiro M; Giménez-Pardo C; Gómez-Barrio A; Franck X; Fournet A; Hocquemiller R; Figadère B; Casado-Escribano N
    Farmaco; 2005 Mar; 60(3):219-24. PubMed ID: 15784240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.